| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.057 | 0.3 |